epsilon-viniferin, epsilon-viniferine
| Name | Epsilon-Viniferin | ||
| PubChem CID | 5281728 | ||
| Molecular Weight | 454.5g/mol | ||
| Synonyms |
epsilon-viniferin, epsilon-viniferine |
||
| Formula | C₂₈H₂₂O₆ | ||
| SMILES | C1=CC(=CC=C1C=CC2=C3C(C(OC3=CC(=C2)O)C4=CC=C(C=C4)O)C5=CC(=CC(=C5)O)O)O | ||
| InChI | 1S/C28H22O6/c29-20-7-2-16(3-8-20)1-4-18-11-24(33)15-25-26(18)27(19-12-22(31)14-23(32)13-19)28(34-25)17-5-9-21(30)10-6-17/h1-15,27-33H/b4-1+/t27-,28+/m1/s1 | ||
| InChIKey | FQWLMRXWKZGLFI-YVYUXZJTSA-N | ||
| CAS Number | 62218-08-0 | ||
| ChEMBL ID | CHEMBL1224875 | ||
| ChEBI ID | CHEBI:10556 | ||
| KEGG ID | C10289 | ||
| Structure | 
|
Download
2D
MOL
3D
MOL
|
|
| Chineses Pinyin | SanLeng | ||
| Use Part | Tuberoid | ||
| Habitat | JiangSu, HeNan, ShanDong, JiangXi | ||
| Flavor | Pungent, Bitter | ||
| Meridian Tropism | Liver, Spleen | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Poales
-->Family: Typhaceae
-->Genus: Sparganium
-->Species: Sparganium stoloniferum
|
||
| Chineses Pinyin | PuTao | ||
| Use Part | Vitis vinifera L | ||
| Flavor | Sweet; Slightly Sour | ||
| Meridian Tropism | Stomach; Liver; Kidney | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Vitales
-->Family: Vitaceae
-->Genus: Vitis
-->Species: Vitis vinifera
|
||
| Pair Name | Epsilon-Viniferin, alpha-Viniferin | |||
| Partner Name | alpha-Viniferin | |||
| Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
| Up-regulation | Cleavage | CASP3 | hsa836 | |
| Down-regulation | Phosphorylation | MAPK8 | hsa5599 | |
| Down-regulation | Phosphorylation | MAPK9 | hsa5601 | |
| Up-regulation | Cleavage | PARP1 | hsa142 | |
| In Vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 |
| Result | ε-viniferin and α-viniferin may prove to be new approaches and effective therapeutic agents for osteosarcoma and lung cancer treatment. | |||
